|Day's Range||24,533.96 - 24,669.79|
|52 Week Range||23,344.52 - 26,951.81|
Yahoo Finance's has a look at this week's Champs & Chumps
Stocks are starting the day higher, as tech stocks rebound. Yahoo Finance’s Seana Smith is at the New York Stock Exchange, where there’s talk of a Santa Claus bounce.
Yahoo Finance's LIVE stock market coverage and analysis.
President Donald Trump touts falling oil prices as a boon to U.S. consumers. That’s true, but economists say the shale revolution, which has transformed the U.S. back into a major oil producer, means that declining crude prices are now a small headwind for the economy thanks to the impact on capital spending by shale producers.
Its doubtful that even Santa can help. An analysis of the past century reveals that the stock market in the weeks prior to Christmas is no more likely to rally than at other times of the year. To be sure, hardly any of the many advisers and commentators who base their hopes on a Santa Claus Rally ever bother to define exactly when it begins and ends.
U.S. markets are on the right track for the first time all week Wednesday, November 21, as the major indices are climbing in morning trading. The Dow and S&P are still negative for the year after a major selloff earlier this week that shaved off many of the market's gains. jumped 15% after the shoe retailer reported earnings of 95 cents per share, which was 3 cents better than analysts were expecting for the quarter.
Wall Street investors appear to be signaling that it can’t withstand an unabated pace of increases to benchmark rates from Federal Reserve Chairman Jerome Powell.
Shares of Johnson & Johnson fell 3.3% in afternoon trade, enough to pace declines among its health care peers and among the Dow Jones Industrial Average's components, after reports that an appeals court ruled that J&J can't block sales of generic Zytiga while the company appeals the overturning of a Zytiga patent. In J&J's third-quarter ended Sept. 30, Zytiga sales rose 43.2% from a year ago to $958 million, making it the company's third-highest selling drug. Jennifer Taubert, worldwide chairman of pharmaceuticals at J&J, said in the company's post-earnings conference call with analysts while the company was "pleased" with Zytiga, "we're absolutely not dependent on it," according to a transcript provided by FactSet. The company said total pharmaceutical operational sales growth was 8.2%, but if Zytiga was removed, growth would have still been a "really strong" 6.6%. The stock has still gained 4.6% over the past three months, while the SPDR Health Care Select Sector ETF has slipped 1.7% and the Dow has lost 4.6%.
Here’s a chart pattern that has at least one stock-market bull looking for a bottom in the tech-led selloff that’s erased year-to-date gains for U.S. stocks.
By Medha Singh (Reuters) - U.S. stocks recouped some losses on Wednesday after a brutal two-day selloff as strong earnings from Foot Locker and gains in technology stocks lifted investor sentiment ahead ...
Foot Locker Inc shares surged 15.9 percent after the footwear retailer's quarterly same-store sales trumped expectations and boosted other sports retailers. Shares of Dick's Sporting Goods Inc and Hibbett Sports Inc rising about 3 percent, while those of Nike Inc, a Foot Locker supplier, gained 1.5 percent. Gains in Foot Locker and Gap helped push the S&P consumer discretionary index 1.7 percent higher.
U.S. stock indexes are broadly higher Wednesday, as they attempt to recapture some of the ugly losses accumulated over the past two sessions on the back of a persistent rout in once-highflying tech stocks.
By April Joyner NEW YORK (Reuters) - World stock markets and oil prices climbed on Wednesday, with earnings and gains in tech stocks lifting shares on Wall Street, while the euro rose on hopes Italy and ...
Cash is king, according to Goldman Sachs strategists who predict that 2019 will deliver lackluster, single-digit equity returns, making greenbacks the best game in town.
President Donald Trump is continuing to call for lower oil prices, despite a drop that sent West Texas Intermediate crude-oil prices (CLF9) into bear-market territory, defined as a drop of at least 20% from a recent peak. The president, who has been critical of the Organization of the Petroleum Exporting Countries and its lead member, Saudi Arabia, on Wednesday morning tweeted: “Oil prices getting lower. Thank you to Saudi Arabia, but let’s go lower!
The Federal Reserve is bent on normalizing interest rates from crisis-era levels. But investors appear to be signaling that the market can’t withstand an unabated pace of rate increases.
The Dow Jones Industrial Average rose more than 100 points Wednesday, halting a selloff that has left investors on edge as to whether the longest bull market ever can regain its step. Signs of slowing economic growth, which have the potential to crimp profits, have been among investors’ biggest worries as companies from Apple to Kellogg have warned of slowing sales in the final months of the year.
Sales of previously owned homes notched their first increase in six months, but remain 5.1% lower than a year ago, with little reason to expect a substantial rebound that will endure.